NLRP3 and obesity disorder: In obesity, reducing the AMP-activated protein kinase (AMPK) AMPK reactivity leads to the inhibition of mitophagy and accumulation of damaged mitochondria and intracellular mtROS, release of mtDNA, and the NLRP3 inflammasome activation [50].